Alphabet's Isomorphic Labs has raised more than $2bn in funds to accelerate AI-powered drug discovery and tech expansion.

Isomorphic, which formed as an Alphabet company in 2021, has a massive cash horde, but it’s tight-lipped on what drugs it might bring to the clinic.

Alphabet's Isomorphic Labs has raised more than $2bn in funds to accelerate AI-powered drug discovery and tech expansion.